98%
921
2 minutes
20
The calcium-sensing receptor (CASR) is expressed in the pancreas where it might regulate calcium concentrations in pancreatic secretions. Two independent studies reported conflicting results claiming that commonly occurring missense variants of the CASR gene are risk factors for chronic pancreatitis (CP). Here, we attempted to replicate the association between CASR variants and CP. We analyzed 337 patients and 840 controls from the Hungarian National Pancreas Registry either by direct sequencing of exon 7 and the flanking noncoding regions or by TaqMan SNP genotyping assays. We identified two common missense variants, c.2956G>T (p.A986S), and c.2968A>G (p.R990G), three low-frequency variants, c.3031C>G (p.Q1011E), c.2610G>A (p.E870=) and c.∗60T>A, and 8 rare variants including the novel variant c.1895G>A (p.G632D). When allelic or genotype distributions were considered, none of the CASR variants associated with CP. Subgroup analysis of nonalcoholic versus alcoholic patients revealed no disease association either. Our results demonstrate that common CASR variants do not modify the risk for CP and should not be considered as genetic risk factors in the clinical setting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663126 | PMC |
http://dx.doi.org/10.1016/j.pan.2021.08.012 | DOI Listing |
Genes (Basel)
August 2025
Endocrinology Unit, Department of Medicine (DIMED), Via Ospedale Civile 105, 35128 Padua, Italy.
This study investigates the role of CASR gene polymorphisms (A986S, R990G, Q1011E) in PHPT genetic susceptibility and its clinical variability. The aim is to evaluate the prevalence of these polymorphisms in patients with sporadic PHPT and their impact on clinical course, biochemistry, and histological features. 106 patients underwent clinical and anamnestic evaluations, focusing on major PHPT complications, as well as biochemical analyses of blood and urine.
View Article and Find Full Text PDFAm J Hum Genet
August 2025
BridgeBio Pharma, 3160 Porter Drive, Suite 250, Palo Alto, CA 94304, USA. Electronic address:
The availability of genomic sequencing has revealed that variants in genes that cause rare monogenic disorders are relatively common, which raises the question of variant pathogenicity. Autosomal-dominant hypocalcemia type 1 (ADH1) is a rare genetic form of hypoparathyroidism caused by gain-of-function (GoF) variants in the calcium-sensing receptor (CaSR) encoded by CASR. We examined the prevalence, penetrance, and expressivity of GoF CASR variants in the UK Biobank (UKB; n = 433,793), All of Us (AOU; n = 229,987), and Mass General Brigham Biobank (n = 39,081).
View Article and Find Full Text PDFFront Genet
May 2025
Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan, China.
Background: Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant disorder and represents a rare cause of hypercalcemia. It stems from variants in the calcium-sensing receptor gene (CaSR), G-protein subunit alpha11 gene (GNA11), or adaptor-related protein complex 2 gene (AP2S1), among which variants in the CaSR gene are the most prevalent. However, challenges in the current diagnosis of FHH persist, owing to the overlap in clinical features with primary hyperparathyroidism (PHPT).
View Article and Find Full Text PDFClin Endocrinol (Oxf)
August 2025
Paediatric Endocrine Department, Sydney Children's Hospital, Sydney, NSW, Australia.
Context: Idiopathic Infantile Hypercalcaemia (IIH) is rare; thus data on investigation, treatment and outcome are limited. Monogenic causes have been implicated in some cases.
Objective: To report on the biochemical profile and response to treatment of infants with IIH and yield of testing for variants in genes involved in calcium sensing and vitamin D metabolism (CASR, AP2S1, GNA11, CYP24A1).
J Clin Invest
August 2025
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
BACKGROUNDKidney stone disease (KSD) affects approximately 10% of adults, is heritable, and is associated with mineral metabolic abnormalities.METHODSGenetic variants and pathways increasing KSD risk via calcium and phosphate homeostasis were ascertained using GWAS, region-specific Mendelian randomization (MR), and genetic colocalization. The utility of pathway modulation was estimated via drug target MR, and the effects of variants on calcium-sensing receptor (CaSR) signaling were characterized.
View Article and Find Full Text PDF